Cencora, Inc.

Cencora, Inc.

Compare this stock

COR Stock Report Card

$

VolatilityProfitPerformanceEarningsDividendAnalyst Price Targets

70%

Performance

Score:

100/100

COR returned 7.05% in the last 12 months. Based on SPY's performance of -13.80%, its performance is above average giving it a score of 100 of 100.

Analyst Price Targets

Score:

68/100

15 analysts offer 12-month price targets for COR. Together, they have an average target of 171, the most optimistic target put COR at 190 within 12-months and the most pessimistic has COR at 150.

Earnings

Score:

100/100

COR has missed earnings 1 times in the last 20 quarters.

Profit

Score:

84/100

Out of the last 20 quarters, COR has had 20 profitable quarters and has increased their profits year over year on 12 of them.

Volatility

Score:

55/100

COR has had a higher than average amount of volatility over the last 12 months giving it a score of 55 of 100.

Dividend

Score:

10/100

COR's most recent dividend was $0.81 per share, based on a share price of $193.22. It was a payout ratio of 182.09% compared to their total earnings.

Cencora, Inc. Summary

New York Stock Exchange / COR
Healthcare
Medical - Distribution
Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.